Recalls / Active ingredient / Ganciclovir Sodium
Ganciclovir Sodium
1 FDA drug recall involving the active ingredient “Ganciclovir Sodium”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-12-16 | Class II | Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by: THYMOORGAN PH | Hikma Pharmaceuticals USA Inc. |